Wordt geladen...
Adipose cells promote resistance of breast cancer cells to trastuzumab-mediated antibody-dependent cellular cytotoxicity
INTRODUCTION: Trastuzumab has been used in the treatment of human epidermal growth factor receptor 2 (HER2)-expressing breast cancer, but its efficacy is limited by de novo or acquired resistance. Although many mechanisms have been proposed to explain resistance to trastuzumab, little is known conce...
Bewaard in:
| Gepubliceerd in: | Breast Cancer Res |
|---|---|
| Hoofdauteurs: | , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2015
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4482271/ https://ncbi.nlm.nih.gov/pubmed/25908175 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-015-0569-0 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|